logo

Did Moderna design its COVID-19 vaccine in two days?

Tuesday, December 29, 2020
By Bennett Murray
YES

Moderna Inc. finalized its design for mRNA-1273, its COVID-19 vaccine, on Jan. 13, 2020, two days after Chinese scientists published the coronavirus's genetic sequence online. The first clinical batch of the vaccine was completed on Feb. 7 and shipped on Feb. 24 in preparation for human trials, which commenced with the first dose on March 16.

According to a University of Virginia medical professor, the new class of mRNA vaccines—which include the Moderna and Pfizer vaccines against COVID-19—are faster to develop in labs since they do not require the production of weakened pathogens or proteins as traditional vaccines do. They still must be tested in carefully-managed trials across diverse demographic groups to confirm their safety and efficacy, which limits how fast they can be deployed against a new health threat.

This fact brief is responsive to conversations such as this one.
ABOUT THE CONTRIBUTOR
Between 2020 and 2022, under close editorial supervision, Gigafact contracted a group of freelance writers and editors to test the concepts for fact briefs and provide inputs to our software development process. We call this effort Gigafact Foundry. Over the course of these two years, Gigafact Foundry writers published over 1500 fact briefs in response to claims they found online. Their important work forms the basis of Gigafact formats and editorial guidelines, and is available to the public on Gigafact.org. Readers should be aware that while there is still a lot of relevant information to be found, not all fact briefs produced by Gigafact Foundry reflect Gigafact's current methods and standards for fact briefs. If you come across any that you feel are out of date and need to be looked at with fresh eyes, don't hesitate to contact us at support@gigafact.org.
FACT BRIEF BY
facebook
twitter
email
email